Infrequent hepatitis C genotypes/subtypes in patients treated with DAA-based regimens: successes and failures
Journal of hepatology(2022)
摘要
Change from primary to secondary pangenotypic regimens (letter abbreviations in abstract, numbers represent weeks of treatment). Conclusion:We have demonstrated a high, almost 90% effectivenes of pangenotypic retreatment after failure of the primary pangenotypic therapy.Only men with cirrhosis, infected with genotype 3, did not eliminate HCV infection despite double pangenotypic treatment.We hope to provide data from more patients at the ILC.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要